Hydrophilic and hydrophobic amino acid copolymers for nano-comminution of poorly soluble drugs

International Journal of Pharmaceutics

Volumn 384, Issue 1-2, 2010, Pages 173-180

  Lee, M K ^a   Kim, S ^a   Ahn, C H ^b   Lee, J ^a  

^a Chung Ang University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Dispersion; Nanocrystals; Nanoparticles; Particle engineering; Particle size; Poorly water soluble drug

Indexed keywords

AMINO ACID COPOLYMER; DIGITOXIN; ELASTIN; GLUTAMIC ACID; GLYCINE; HYDROCORTISONE ACETATE; IBUPROFEN; ITRACONAZOLE; LEUCINE; LYSINE; NANOPARTICLE; NAPROXEN; NIFEDIPINE; PHENYLALANINE; PREDNISOLONE ACETATE; PROLINE; STABILIZING AGENT; VALINE;

AMINO ACID COMPOSITION; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; HYDROPHILICITY; HYDROPHOBICITY; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TEMPERATURE DEPENDENCE;

AMINO ACID SEQUENCE; AMINO ACIDS; HYDROPHOBICITY; MOLECULAR SEQUENCE DATA; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; POLYMERS; SOLUBILITY;

EID: 70649087925     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.09.041     Document Type: Article

References (54)

1. Abdelwahed W., Degobert G., Stainmesse S., and Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv. Drug Deliv. Rev. 58 (2006) 1688-1713
2. Adamson A.W., and Gast A.P. Physical Chemistry of Surfaces (1997), John Wiley & Sons pp. 348, 506
3. Amidon G.L., Leenernäs H., Shah V.P., and Crison J.R. Theoretical basis for a biopharmaceutical drug classification: the correlation of in vivo drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (1995) 413-420
4. Berglund K.D., Przybycien T.M., and Tilton R.D. Coadsorption of sodium dodecyl sulfate with hydrophobically modified nonionic cellulose polymers. 1. Role of polymer hydrophobic modification. Langmuir 19 (2003) 2705-2713
5. Berglund K.D., Przybycien T.M., and Tilton R.D. Coadsorption of sodium dodecyl sulfate with hydrophobically modified nonionic cellulose polymers. 2. Role of surface selectivity in adsorption hysteresis. Langmuir 19 (2003) 2714-2721
6. Choi J.-Y., Yoo J.Y., Kwak H.-S., Nam B.U., and Lee J. Role of polymeric stabilizers for drug nanocrystal dispersions. Curr. Appl. Phys. 5 (2005) 472-474
7. Craig D.Q.M. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 231 (2002) 131-144
8. Daly W.H., and Poche D. The preparation of N-carboxyanhydrides of α-amino acids using bis (trichlorometyl)carbonate. Tetrahedron Lett. 29 (1988) 5859-5862
9. Deming T.J. Facile synthesis of block copolypeptides of defined architecture. Nature 390 (1997) 386-389
10. Deming T.J. Polypeptide materials: new synthetic methods and applications. Adv. Mater. 9 (1997) 299-311
11. Deming T.J. Living polymerization of alpha-amino acid-N-carboxyanhydrides. J. Polym. Sci. Polym. Chem. 38 (2000) 3011-3018
12. Elkharraz K., Faisant N., Guse C., Siepmann F., Arica-Yegin B., Oger J.M., Gust R., Goepferich A., Benoit J.P., and Siepmann J. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization. Int. J. Pharm. 314 (2006) 127-136
13. Evertsson H., and Nilsson S. Microviscosity in clusters of ethyl hydroxyethyl cellulose and sodium dodecyl sulfate formed in dilute aqueous solutions as determined with fluorescence probe techniques. Macromolecules 30 (1997) 2377-2385
14. Frick A., Möller H., and Wirbitzki E. Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin. Eur. J. Pharm. Biopharm. 46 (1998) 305-311
15. Godwin D.A., Wiley C.J., and Felton L.A. Using cyclodextrin complexation to enhance secondary photoprotection of topically applied ibuprofen. Eur. J. Pharm. Biopharm. 62 (2006) 85-93
16. Grau M.J., Kayser O., and Müller R.H. Nanosuspensions of poorly soluble drugs-reproducibility of small scale production. Int. J. Pharm. 196 (2000) 155-157
17. Guda C., Zhang X., McPherson D.T., Xu J., Cherry J.H., Urry D.W., and Daniell H. Hyper expression of an environmentally friendly synthetic polymer gene. Biotechnol. Lett. 17 (1995) 745-750
18. Hanson J.A., Chang C.B., Graves S.M., Li Z., Mason T.G., and Deming T.J. Nanoscale double emulsions stabilized by single-component block copolypeptides. Nature 455 (2008) 85-88
19. Hill T.L. A different approach to nanothermodynamics. Nano Lett. 1 (2001) 273-275
20. Kendall K. The impossibility of comminuting small particles by compression. Nature 272 (1978) 710-711
21. Kesisoglou F., Panmai S., and Wu Y. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 59 (2007) 631-644
22. Kricheldorf H.R. α-Amino acid N-carboxyanhydrides and related heterocycles (1987), Springer-Verlag, Berlin pp. 1-213
23. Lee J. Drug nano- and microparticles processed into solid dosage forms: physical properties. J. Pharm. Sci. 92 (2003) 2057-2068
24. Lee J., Choi J.-Y., and Park C.H. Characteristics of polymers enabling nano-comminution of water-insoluble drugs. Int. J. Pharm. 355 (2008) 328-336
25. Lee J., Choi J.-Y., and Park C.H. Effect of polymer molecular weight on nanocomminution of poorly soluble drug. Drug Deliv. 15 (2008) 347-353
26. Lee J., Lee S.-J., Choi J.-Y., Yoo J.Y., and Ahn C.-H. Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion. Eur. J. Pharm. Sci. 24 (2005) 441-449
27. Lee J., Lim G.-B., and Chung H. Preparation methods of drug nanoparticles. In: Kumar C.S.S.R. (Ed). Biological and Pharmaceutical Nanomaterials (Nanotechnologies for the Lifesciences) vol. 2 (2006), Wiley Science
28. Lee J., Macosko C.W., and Urry D.W. Mechanical properties of cross-linked artificial polypeptides. Macromolecules 34 (2001) 5968-5974
29. Lee J., Macosko C.W., and Urry D.W. Swelling behavior of gamma-irradiation cross-linked elastomeric polypentapeptide-based hydrogels. Macromolecules 34 (2001) 4114-4123
30. Lee J., Macosko C.W., and Urry D.W. Elastomeric polypentapeptides cross-linked into matrices and fibers. Biomacromolecules 2 (2001) 170-179
31. Lee R.W., Mcshane J., Shaw J.M., and Wood R.W. Particle size reduction. In: Liu R. (Ed). Water-insoluble Drug Formation (2000), Interpharm Press, Buffalo Grove 455-492
32. Leuner C., and Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50 (2000) 47-60
33. Liversidge G.G., and Conzentino P. Drug particle size reduction for decreasing gastic irritancy and enhancing absorption of naproxen in rats. Int. J. Pharm. 125 (1995) 309-313
34. Liversidge G.G., and Cundy K. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs. I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharm. 125 (1995) 91-97
35. McPherson D.T., Xu J., and Urry D.W. Product purification by reversible phase transition following Escherichia coli expression of genes encoding up to 251 repeats of the elastomeric pentapeptide GVGVP. Protein Exp. Purif. 7 (1996) 51-57
36. Merisko-Liversidge E., Sarpotdar P., Bruno J., Hajj S., Wei L., Peltier N., Rake J., Shaw J.M., Pugh S., Pollin L., Jones J., Corbett T., Cooper E., and Liversidge G.G. Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm. Res. 13 (1996) 272-278
37. Morrison I.D., and Ross S. Colloidal Dispersions (2002), Wiley-Interscience p. 402
38. Ploehn H.J., and Russell W.B. Interactions between colloidal particles and soluble polymers. Adv. Chem. Eng. 15 (1990) 137-228
39. Rasenack N., and Muller B.W. Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs. Pharm. Res. 19 (2002) 1894-1900
40. Schonert K. Aspects of very fine grinding. In: Sastry K.V.S., and Fuerstenau M.C. (Eds). Challenges in Mineral Processing (1989), Society of Mining Engineers, Inc., Littleton, CO 155-172
41. Schonert K. Comminution from theory to practice. The Proceedings of the XIX International Mineral Processing Congress. SME, Littleton, CO (1995) 7-14
42. Sepassi S., Goodwin D.J., Drake A.F., Holland S., Leonald G., Martini L., and Lawrence M.J. Effect of polymer molecular weight on the production of drug nanoparticles. J. Pharm. Sci. 96 (2007) 2655-2666
43. Serajuddin A.T.M. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88 (1999) 1058-1066
44. Six K., Verreck G., Peeters J., Brewster M., and van den Mooter G. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. J. Pharm. Sci. 93 (2004) 124-131
45. Takano R., Sugano K., Higashida A., Hayashi Y., Machida M., Aso Y., and Yamashita S. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test. Pharm. Res. 23 (2006) 1144-1156
46. Torchilin V. Drug targeting. Eur. J. Pharm. Sci. 11 Suppl. 2 (2000) S81
47. Urry D.W., Pattanaik A., Xu J., Woods T.C., McPherson D.T., and Parker T.M. Elastic protein-based polymers in soft tissue augmentation and generation. J. Biomater. Sci. Polym. Ed. 9 (1998) 1015-1048
48. Urry D.W. Physical chemistry of biological free energy transduction as demonstrated by elastic protein-based polymers. J. Phys. Chem. B 101 (1997) 11007-11028
49. Van Dijk-Wolthuis W.N.E., Van de Water L., Van de Wetering P., Van Steenbergen M., Kettenes-Van den Bosch J.J., Schuyl W., and Hennink W.E. Synthesis and characterization of poly (l-lysine) with controlled low molecular weight. Macromol. Chem. Phys. 198 (1997) 3893-3906
50. Verreck G., Decorte A., Heymans K., Adriaensen J., Cleeren D., Jacobs A., Liu D., Tomasko D., Arien A., Peeters J., Rombaut P., Mooter G.V., and Brewster M.E. The effect of pressurized carbon dioxide as a temporary plasticizer and foaming agent on the hot stage extrusion process and extrudate properties of solid dispersions of itraconazole with PVP-VA 64. Eur. J. Pharm. Sci. 26 (2005) 349-358
51. Yamada T., Saito N., and Imai T. Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug. Chem. Pharm. Bull. 47 (1999) 1311-1313
52. Yang C., Song B., Ao Y., Nowak A.P., Abelowitz R.B., Korsak R.A., Havton L.A., Deming T.J., and Sofroniew M.V. Biocompatibility of amphiphilic diblock copolypeptide hydrogels in the central nervous system. Biomaterials 30 (2009) 2881-2898
53. Yin S.X., Franchini M., Chen J., Hsieh A., Jen S., Lee T., Hussain M., and Smith R. Bioavailability enhancement of a COX-2 inhibitor. BMS-347070, from a nanocrystalline dispersion prepared by spray-drying. J. Pharm. Sci. 94 (2005) 1598-1607
54. Zheng J.Y., and Bosch H.W. Sterile filtration of nanocrystal drug formulation. Drug Dev. Ind. Pharm. 23 (1997) 1087-1093